Anne Tsao | Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

Sun	Mon	Tue	Wed	Thu	Fri	Sat
23	24	25	26	27	28	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Dr. Tsao was a medical student at the University of Chicago Pritzker School of Medicine and studied as an intern and resident at the University of Indiana. With two board certifications in medical oncology and internal medicine, Dr. Anne Tsao is the director of the mesothelioma and thoracic chemo-radiation programs at University of Texas M.D. Anderson Cancer Center. Her specialty is mesothelioma and this has led her to conduct studies, clinical trials and a lot of research into producing and improving modern mesothelioma treatment methods. Dr. Anne Tsao has also occupied the position of Thoracic, Head and Neck Medical Oncology professor.

University of Chicago Pritzker School of Medicine - 1998

Medical School

University of Indiana

Internship

Indiana University and University of Texas

Residency

University of Texas

Fellowship

American Board of Internal Medicine - Oncology

University of Texas MD Anderson Cancer Center

Languages: English/Spanish

713-792-2121

1515 Holcombe Blvd

Houston, Texas 77030

The Battle Trial: Personalizing Therapy for Lung Cancer.

Linda Garland, , Raja Flores, Anne Tsao

Individualizing mesothelioma treatment: small steps into a brighter future.

Garland L, Flores R, Tsao A.

VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and b

Carbone DP, Salmon JS, Billheimer D, Chen H, Sandler A, Roder H, Roder J, Tsypin M, Herbst RS, Tsao AS, Tran HT, Dang TP.

Meta-anlysis of the impact of human papilomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

Dayyani F1, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS.

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Tsao AS1, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V.

Memberships

American Radium Society

American Society of Clinical Oncology

Southwestern Oncology Group

Bio & Insurance Information

Dr. Tsao was a medical student at the University of Chicago Pritzker School of Medicine and studied as an intern and resident at the University of Indiana. With two board certifications in medical oncology and internal medicine, Dr. Anne Tsao is the director of the mesothelioma and thoracic chemo-radiation programs at University of Texas M.D. Anderson Cancer Center. Her specialty is mesothelioma and this has led her to conduct studies, clinical trials and a lot of research into producing and improving modern mesothelioma treatment methods. Dr. Anne Tsao has also occupied the position of Thoracic, Head and Neck Medical Oncology professor.
Education & Training

University of Chicago Pritzker School of Medicine - 1998
Medical School
University of Indiana
Internship
Indiana University and University of Texas
Residency
University of Texas
Fellowship
Board Certifications

American Board of Internal Medicine - Oncology
Hospital & Practice

University of Texas MD Anderson Cancer Center

Languages: English/Spanish

713-792-2121

1515 Holcombe Blvd

Houston, Texas 77030
Read More
Publications & Memberships

Dr. Anne Tsao has contributed to 5 publications.

The Battle Trial: Personalizing Therapy for Lung Cancer.

Linda Garland, , Raja Flores, Anne Tsao
See more >>

Individualizing mesothelioma treatment: small steps into a brighter future.

Garland L, Flores R, Tsao A.
See more >>

VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and b

Carbone DP, Salmon JS, Billheimer D, Chen H, Sandler A, Roder H, Roder J, Tsypin M, Herbst RS, Tsao AS, Tran HT, Dang TP.
See more >>

Meta-anlysis of the impact of human papilomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

Dayyani F1, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS.
See more >>

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Tsao AS1, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V.
See more >>

Memberships

American Radium Society

American Society of Clinical Oncology

Southwestern Oncology Group

Request a call back

Request a call back

Dr. Anne Tsao has contributed to 5 publications.

Dr. Anne Tsao has contributed to 5 publications.

Sun	Mon	Tue	Wed	Thu	Fri	Sat
23	24	25	26	27	28	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Sun	Mon	Tue	Wed	Thu	Fri	Sat
23	24	25	26	27	28	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Sun	Mon	Tue	Wed	Thu	Fri	Sat
23	24	25	26	27	28	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Sun	Mon	Tue	Wed	Thu	Fri	Sat
23	24	25	26	27	28	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Sun	Mon	Tue	Wed	Thu	Fri	Sat
23	24	25	26	27	28	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Sun	Mon	Tue	Wed	Thu	Fri	Sat
23	24	25	26	27	28	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5